Evidence map›Paper›PMID 27087247›Full record

ArticleScientific reports2016

Altered Mucosal Microbiome Diversity and Disease Severity in Sjögren Syndrome.

Cintia S de Paiva, Dan B Jones, Michael E Stern, Fang Bian, Quianta L Moore, Shani Corbiere, Charles F Streckfus, Diane S Hutchinson, Nadim J Ajami, Joseph F Petrosino and 1 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03926286 (Fecal Microbial Transplant for Sjogrens Syndrome), which is not on this map. Cited by 208 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
208citing papers in PubMed, 11 pooled it
17.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03926286 phase1completednot on this mapstarted 2019, after this paper: background citation

Fecal Microbial Transplant for Sjogrens Syndrome

TypeinterventionalSponsorUniversity of MiamiRan2019 to 2020Enrolled10ConditionsSjogren's SyndromeArmsFMP-30
3 · Its place in the literature

Who cites it

208 citing papers in PubMed, 11 syntheses or guidelines pooled it, 352 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Pooled it
  12. Trial
  13. Trial
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

148 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Cintia S de PaivaDepartment of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Dan B JonesDepartment of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Michael E SternBiological Sciences, Allergan, Irvine, CA, USA.
Fang BianDepartment of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Quianta L MooreDepartment of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Shani CorbiereSjogren Syndrome Support Group, Houston, TX, USA.
Charles F StreckfusDental Branch, Department of Diagnostic and Biomedical Sciences, University of Texas Health Science Center (UTHSC), Houston, TX, USA.
Diane S HutchinsonAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Nadim J AjamiAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Joseph F PetrosinoAlkek Center for Metagenomics and Microbiome Research, Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Stephen C PflugfelderDepartment of Ophthalmology, Baylor College of Medicine, Houston, TX, USA.
Baylor College of Medicine · USAllergan (United States) · USRome Foundation · USUniversity of Tennessee Health Science Center · US

Funding

VISION RESEARCH CENTERP30EY002520 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$14.8M
Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
VISUAL SCIENCEST32EY007001 · NEI · BAYLOR COLLEGE OF MEDICINE · PI Samuel M Wu · 1985 to 2026
$3.7M
NEI NIH HHS P30 EY002520NEI NIH HHS T32 EY007001NEI NIH HHS T32-EY07001-37NIAID NIH HHS T32 AI053831NIAID NIH HHS T32-AI053831
6 · The paper itself

Abstract

There is mounting evidence that the microbiome has potent immunoregulatory functions. We assessed the effects of intestinal dysbiosis in a model of Sjögren syndrome (SS) by subjecting mice to desiccating stress (DS) and antibiotics (ABX). We characterized the conjunctival, tongue and fecal microbiome profiles of patients with SS. Severity of ocular surface and systemic disease was graded. 16S ribosomal RNA gene sequencing characterized the microbiota. ABX + DS mice had a significantly worse dry eye phenotype compared to controls, a decrease in Clostridium and an increase in Enterobacter, Escherichia/Shigella, and Pseudomonas in stool after ABX + DS for 10 days. Goblet cell density was significantly lower in ABX treated groups compared to controls. Stool from SS subjects had greater relative abundances of Pseudobutyrivibrio, Escherichia/Shigella, Blautia, and Streptococcus, while relative abundance of Bacteroides, Parabacteroides, Faecalibacterium, and Prevotella was reduced compared to controls. The severity of SS ocular and systemic disease was inversely correlated with microbial diversity. These findings suggest that SS is marked by a dysbiotic intestinal microbiome driven by low relative abundance of commensal bacteria and high relative abundance of potentially pathogenic genera that is associated with worse ocular mucosal disease in a mouse model of SS and in SS patients.

Indexed as

MicrobiotaAnimalsAnti-Bacterial AgentsConjunctivaDry Eye SyndromesDysbiosisFecesFemaleHumansIntestinal MucosaMice, Inbred C57BLMouth MucosaScopolamineSjogren's SyndromeTongueAnti-Bacterial AgentsScopolamine

Identifiers

PMID27087247
PMCPMC4834578
OpenAlexW2341975873

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.